Amgen earnings boosted by higher drug prices, lower R&D

April 21, 2015 10:19 PM

57 0

Amgen earnings boosted by higher drug prices, lower R&D

(Reuters) - Amgen Inc reported higher first-quarter earnings on Tuesday, helped by price increases for its best-selling drugs, as well as lower spending on research and development.

Amgen shares, which rose 1.5 percent in regular trading, were up another 2.3 percent at $172.25 after hours.

Also read: Trump’s 15% Corporate Tax Seen as ‘Gambit’ as He Unveils Plan

Read more

To category page

Loading...